Neonatal Infectious Diseases/Immunology 2: Congenital infections

Neonatal Infectious Diseases/Immunology 2: Congenital infections

575 - In-utero exposure to substance use in pregnant people living with HIV is associated with adverse pregnancy outcomes and poor placental health

584 - Epidemiology of Neonatal Herpes Simplex Virus Infection 2008-2023

585 - Impact of COVID-19 in pregnancy on infant neurodevelopmental outcomes at 18 months: a case-control study

586 - Effect of Maternal Antibiotics Administered within Seven Days Before Delivery on Early Neonatal Mortality: A Retrospective Propensity Score-Matched Analysis

587 - Exposure to Diabetes in utero inhibits post-partem T cell memory development in Preterm Infants.

588 - Implementation of Updated Perinatal Maternal Fetal HIV Transmission Guidelines

589 - A congenital CMV infection and placental histopathology cohort study using spatial transcriptomics and a novel human placental villous model system to understand mechanisms of vertical transmission.

576 - Investigating Guideline Directed Outpatient Laboratory Monitoring among Cases of Congenital Syphilis at a Tertiary Care Children’s Hospital

577 - Placental neutrophil extracellular traps associate with human preeclampsia

578 - Procoagulant platelets and neutrophil extracellular traps may induce intrauterine growth restriction in a murine model of preeclampsia

581 - Comparison of Plasma Cytokines in Infants with Perinatal HIV Exposure Without Infection (HEU) and SARS-CoV-2 Exposure Without Infection (SEU)

582 - Targeted Urine Screening for Congenital Cytomegalovirus Infection in High-Risk Neonates

583 - Challenges in Diagnosis and Treatment of Congenital Syphilis - Can we do better?